Dr. Vikranth R. Gongidi, D.O.
Cardiology (Cardiovascular Disease Physician)
- Medicare participating
At a glance
- Years since graduation
- 20
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 242
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Cardiovascular Disease Physician primary
FL license OS11675 · NJ license MB08595000 -
Internal Medicine Physician
MI license 5101016957
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Cleveland Clinic Indian River Hospital Vero Beach, FL
Medical groups
- Premier Cardiology of Vero Beach (2 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 242
- Services billed
- 3,829
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 752 | 652 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 509 | 482 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 335 | 328 |
| Heart muscle strain imaging | 269 | 264 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 254 | 104 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 199 | 37 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 158 | 31 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 139 | 139 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 134 | 134 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 127 | 127 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Rosuvastatin Calcium Other prescribers in Vero Beach, FL | 115 |
| Metoprolol Succinate Other prescribers in Vero Beach, FL | 76 |
| Eliquis (apixaban) Other prescribers in Vero Beach, FL | 75 |
| Atorvastatin Calcium Other prescribers in Vero Beach, FL | 62 |
| Jardiance (empagliflozin) Other prescribers in Vero Beach, FL | 60 |
| Losartan Potassium Other prescribers in Vero Beach, FL | 51 |
| Entresto (sacubitril/valsartan) Other prescribers in Vero Beach, FL | 43 |
| Carvedilol Other prescribers in Vero Beach, FL | 41 |
| Furosemide Other prescribers in Vero Beach, FL | 35 |
| Amlodipine Besylate Other prescribers in Vero Beach, FL | 34 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 17 companies reported 37 payments worth $1,558 in total to this clinician.
| Actelion Pharmaceuticals US, Inc. | $264 |
|---|---|
| Cvrx, Inc. | $206 |
| Abbott Laboratories | $200 |
| Bayer HealthCare Pharmaceuticals Inc. | $169 |
| Atricure, Inc. | $157 |
| Bridgebio Pharma, Inc. | $150 |
| Merck Sharp & Dohme LLC | $73.24 |
| Novartis Pharmaceuticals Corporation | $70.75 |
| Food and Beverage | $1,459 |
|---|---|
| Education | $98.99 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. May 28, 2025 | Education OPSUMIT; UPTRAVI · Cardiology · in-kind | $98.99 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.